Severe malaria, pascalian therapeutics, and the US Food and Drug Administration (FDA)

Antzeko izenburuak

• Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
  nork: Watson, JA, et al.
  Argitaratua: (2023)
• The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
  nork: Watson, JA, et al.
  Argitaratua: (2023)
• Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
  nork: Alexander C. Martins, et al.
  Argitaratua: (2024-09-01)
• Medical Economics: End the FDA (Food and Drug Administration)
  nork: John Romanach, et al.
  Argitaratua: (2017-03-01)
• Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
  nork: Watson, JA, et al.
  Argitaratua: (2022)